Advertisement Fidelity
Home > Boards > Free Zone > Health and Sciences >

Biotech Values

RSS Feed
      Hide Sticky   Hide Intro
Moderator: DewDiligence Assistants: Biowatch
Search This Board:
Last Post: 4/17/2014 9:09:12 PM - Followers: 1070 - Board type: Free - Posts Today: 37
PostSubject
#176956  Sticky Note PFE, TEVA settle US Celebrex patent case: DewDiligence 04/17/14 04:30:15 PM
#176947  Sticky Note GLPG: GSK2586184 met primary endpoint in Phase jq1234 04/17/14 02:59:13 PM
#176945  Sticky Note I've been a lurker here on this board Swick984 04/17/14 02:11:48 PM
#176843  Sticky Note Biotech Carnage - here's a list of Biotechs researcher59 04/15/14 07:57:23 PM
#176826  Sticky Note According to IPO research firm Renaissance Capital, the researcher59 04/15/14 05:55:24 PM
#176777  Sticky Note The Seeking Alpha author plainly doesn’t understand GILD’s DewDiligence 04/14/14 05:21:49 PM
#176966   I was able to figure out how to Rocky3 04/17/14 10:51:06 PM
#176965   QURE - Baxter was a previously partner with mcbio 04/17/14 09:09:12 PM
#176964   QURE - uniQure/Chiesi's hemophilia program is still in guerlain 04/17/14 07:47:51 PM
#176963   QURE - Baxter was a previously partner with Swick984 04/17/14 07:27:43 PM
#176962   GLPG.BRPreliminary results showed that a significantly higher proporti mcbio 04/17/14 07:01:14 PM
#176961   A few weeks ago, a competitor was bought mcbio 04/17/14 06:52:25 PM
#176960   S&P 500 finishes holiday-shortened week +2.7% (eom). DewDiligence 04/17/14 06:21:10 PM
#176959   NAVB issues PR update on Lymphoseek: DewDiligence 04/17/14 06:12:07 PM
#176958   China backtracks a little on drug pricing: DewDiligence 04/17/14 05:45:29 PM
#176957   GILD—England will pay for ~500 HCV patients suffering DewDiligence 04/17/14 04:50:34 PM
#176956   PFE, TEVA settle US Celebrex patent case: DewDiligence 04/17/14 04:30:15 PM
#176955   $GILD I did tweet that it would cross 70 zipjet 04/17/14 04:13:13 PM
#176954   Did you predict that GILD would close today DewDiligence 04/17/14 03:48:59 PM
#176953   FDA approves MRK’s Ragwitek for ragweed allergy: DewDiligence 04/17/14 03:35:14 PM
#176951   The $60 million of EV did not include Swick984 04/17/14 03:13:11 PM
#176950   How much are you figuring for Sovaldi’s 1Q14 DewDiligence 04/17/14 03:11:43 PM
#176949   GILD earnings and Sovaldi sales: Rocky3 04/17/14 03:02:36 PM
#176948   QURE—One reason for the recent sell-off could be DewDiligence 04/17/14 03:02:26 PM
#176947   GLPG: GSK2586184 met primary endpoint in Phase jq1234 04/17/14 02:59:13 PM
#176946   RBC-Q1 should drive stock higher. Potential for large ariadndndough 04/17/14 02:22:03 PM
#176945   I've been a lurker here on this board Swick984 04/17/14 02:11:48 PM
#176944   Crutch, You've got a link to the PPHM Credit goodJohnhunting 04/17/14 12:17:45 PM
#176943   Goldman is very good making money for itself caravon 04/17/14 12:00:20 PM
#176942   From a Goldman report on 4/15 on JNJ Rocky3 04/17/14 11:07:14 AM
#176941   New kind of trial aims to speed cancer biocqr 04/17/14 09:43:08 AM
#176940   When Use Of Pseudo-Maths Adds Up To Fraud hptaxis 04/17/14 06:20:53 AM
#176939   I had this exact situation. I had Double_Bagel 04/17/14 04:36:51 AM
#176938   No, as pre-condition of Fabrazyme AA by FDA, iwfal 04/17/14 03:13:42 AM
#176937   Well, that's if it is a standard ph3. jq1234 04/17/14 02:06:58 AM
#176936   No, as pre-condition of Fabrazyme AA by FDA, jq1234 04/17/14 02:01:10 AM
#176935   Most phase 3 trial designs are resolved in masterlongevity 04/17/14 01:45:58 AM
#176934   Neither approval of Fabrazyme nor Myzoyme prevented subsequent iwfal 04/17/14 01:22:03 AM
#176933   As far as I know, they haven't received jq1234 04/17/14 12:36:43 AM
#176932   I am not saying SRPT did everything right jq1234 04/17/14 12:21:37 AM
#176931   Re RNA/SRPT pcrutch 04/17/14 12:07:11 AM
#176930   Re SRPT pcrutch 04/17/14 12:01:09 AM
#176929   Re ALNY pcrutch 04/16/14 11:37:34 PM
#176928   >> NO basis is a bit strong. Im jq1234 04/16/14 11:17:37 PM
#176927   A holding period of one year plus one mcbio 04/16/14 10:40:33 PM
#176926   A holding period of one year plus one DewDiligence 04/16/14 10:39:16 PM
#176925   O/T - Long-term cap gains mcbio 04/16/14 10:19:04 PM
#176924   An open letter to Congressman Waxman on the biocqr 04/16/14 10:04:26 PM
#176923   Youre about 2 weeks late.... BTH 04/16/14 10:01:41 PM
#176922   I thought Joshua Brown was shooting from the biotech_researcher 04/16/14 09:11:06 PM
#176921   Must mean quarterly masterlongevity 04/16/14 09:03:26 PM
#176920   Sovaldi is…expected to generate $2.5 billion in sales DewDiligence 04/16/14 08:59:09 PM
#176919   GILEAD- Outrageous gains are not limited to smaller biotech_researcher 04/16/14 08:47:58 PM
#176918   TAUG news today, up 26% Danny1911 04/16/14 08:00:27 PM
#176917   NO basis is a bit strong. Im masterlongevity 04/16/14 07:31:31 PM
#176916   I am not defending ALNY in particular one jq1234 04/16/14 07:31:25 PM
PostSubject